To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TBC1D24andATP6V0CTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
498 supporting clones for gene TBC1D24andATP6V0C back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB502995 hypothalamus .a 1 to 345 1 to 345   tiling clone,   345/345
(100 %)
3 diff
(99.2 %id)
AB032997 brain .a 68 to 4391 17 to 4340 F295L tiling clone, available from KIAA,   4324/4340
(99 %)
6 diff
(99.9 %id)
BC127015 PCR rescued clones .a 131 to 2553 1 to 2423 exact tiling clone,   2423/2423
(100 %)
0 diff
(100 %id)
AB449911 brain .a 185 to 1864 1 to 1680 F295L     1680/1680
(100 %)
2 diff
(99.9 %id)
DA779502 brain .a 751 to 1321 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BC112389 Eye, retinoblastoma .b 1 to 4329 1 to 4329 exact tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 4329/4329
(100 %)
1 diff
(100.0 %id)
NM_020705.1   .b 1 to 4329 1 to 4329 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 4329/4329
(100 %)
1 diff
(100.0 %id)
BM479427 eye, retinoblastoma .b 2 to 912 1 to 915       915/1055
(86 %)
14 diff
(98.7 %id)
CN357355 embryonic stem cells, cell lines H1, H7, andH9 .b 8 to 568 1 to 561       561/561
(100 %)
0 diff
(100 %id)
BF972855 leiomyosarcoma cell line, uterus .b 20 to 847 1 to 816   available from MGC,   816/901
(90 %)
46 diff
(94.9 %id)
BX443072 B cells (Ramos cell line) .b 24 to 984 1 to 960       960/960
(100 %)
8 diff
(99.2 %id)
DN999457   .b 24 to 651 20 to 646       627/646
(97 %)
7 diff
(99.0 %id)
BY799184 eye .b 29 to 632 1 to 605       605/605
(100 %)
1 diff
(99.9 %id)
BC127014 PCR rescued clones .b 87 to 2491 1 to 2405 exact     2405/2405
(100 %)
0 diff
(100 %id)
BF756334 colon .b 512 to 762 1 to 251       251/251
(100 %)
3 diff
(98.9 %id)
BF756369 colon .b 518 to 762 1 to 247       247/247
(100 %)
16 diff
(93.6 %id)
BX431688 B cells (Ramos cell line) .b 783 to 1648 1 to 862       862/919
(93 %)
18 diff
(98.1 %id)
CK430754 eye, lacrimal gland .b 1568 to 2217 1 to 650       650/650
(100 %)
0 diff
(100 %id)
CD517561 White Matter .b 1605 to 2390 1 to 799       799/923
(86 %)
21 diff
(97.8 %id)
BF943762 nervous_normal .b 1885 to 2169 300 to 10     Submitted on the opposite strand 291/300
(97 %)
0 diff
(100 %id)
BE883333 leiomyosarcoma, uterus .b 2147 to 2701 1 to 576       576/580
(99 %)
41 diff
(93.0 %id)
AA325444 brain, cerebellum .b 2522 to 2803 1 to 282       282/282
(100 %)
0 diff
(100 %id)
BQ422810 embryonal carcinoma, cell line, testis .b 2552 to 3302 1 to 760   tiling clone,   760/919
(82 %)
14 diff
(98.5 %id)
BI083795 epidermoid carcinoma, cell line, salivary gland .b 2634 to 3417 1 to 782       782/782
(100 %)
22 diff
(97.2 %id)
BQ644641 hepatocellular carcinoma, cell line, Liver .b 2686 to 3521 1 to 840       840/845
(99 %)
28 diff
(96.7 %id)
BQ646640 hepatocellular carcinoma, cell line, Liver .b 2686 to 3579 1 to 901       901/957
(94 %)
25 diff
(97.4 %id)
BG818357 anaplastic oligodendroglioma with 1p/19qloss, brain .b 2786 to 3467 1 to 692       692/985
(70 %)
28 diff
(97.2 %id)
BX414001 B cells (Ramos cell line) .b 2796 to 3698 901 to 1       901/901
(100 %)
13 diff
(98.6 %id)
DA568634 whole embryo, mainly head .b 2837 to 3586 2 to 753   capped   752/752
(100 %)
9 diff
(98.9 %id)
AK074509 whole embryo, mainly head .b 2843 to 4329 8 to 1494   available from FLJ,   1487/1487
(100 %)
0 diff
(100 %id)
CN357356 embryonic stem cells, DMSO-treated H9 cellline .b 2907 to 3604 1 to 699       699/699
(100 %)
2 diff
(99.8 %id)
BM691874 eye, human retina .b 2936 to 3278 2 to 344   fully sequenced,   343/344
(99 %)
5 diff
(98.6 %id)
BE395335 endometrium, adenocarcinoma cell line, uterus .b 3176 to 3703 1 to 536       536/536
(100 %)
12 diff
(97.8 %id)
CF141801 CNCAP(3)T-225 cell line, Prostate .b 3186 to 3555 8 to 377       370/377
(98 %)
6 diff
(98.5 %id)
TI_154172640   .b 3186 to 3586 80 to 480       401/728
(55 %)
4 diff
(99.5 %id)
AW295901   .b 3222 to 3702 498 to 18   AAA   481/481
(100 %)
1 diff
(99.8 %id)
BF057835 pooled germ cell tumors .b 3222 to 3705 484 to 1       484/488
(99 %)
0 diff
(100 %id)
BE465977 pooled germ cell tumors .b 3243 to 3703 465 to 5       461/465
(99 %)
0 diff
(100 %id)
AI621269 pooled germ cell tumors .b 3245 to 3705 461 to 1       461/461
(100 %)
0 diff
(100 %id)
BU728576 eye, human retina .b 3248 to 3700 473 to 21   fully sequenced,   453/473
(95 %)
1 diff
(99.8 %id)
BE465983 pooled germ cell tumors .b 3251 to 3705 455 to 1       455/455
(100 %)
0 diff
(100 %id)
EC467823 Prostate .b 3293 to 3387 1 to 95       95/95
(100 %)
4 diff
(95.8 %id)
BQ417292 Pancreas, Purified pancreatic islet .b 3320 to 3862 11 to 553       543/553
(98 %)
6 diff
(99.0 %id)
M79058   .b 3321 to 3522 1 to 201       201/201
(100 %)
1 diff
(99.6 %id)
EC584664 Prostate .b 3339 to 3441 1 to 106       106/108
(98 %)
5 diff
(95.4 %id)
CK825938 Pancreas, Purified pancreatic islet .b 3352 to 3946 1 to 595     Submitted on the opposite strand 595/595
(100 %)
0 diff
(100 %id)
H62533 liver and spleen .b 3391 to 3804 1 to 427     Submitted on the opposite strand 427/458
(93 %)
22 diff
(95.2 %id)
DB355167 whole embryo, mainly head .b 3780 to 4329 551 to 1       551/551
(100 %)
14 diff
(97.5 %id)
AA716567 heart .b 3933 to 4083 150 to 1       150/150
(100 %)
2 diff
(98.7 %id)
F01479 brain, total brain .b 4112 to 4329 218 to 1       218/218
(100 %)
0 diff
(100 %id)
AI244842 Kidney .b 4180 to 4329 150 to 1       150/150
(100 %)
0 diff
(100 %id)
BC010147 Uterus, leiomyosarcoma .c 1 to 1941 15 to 1955 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1946/1946
(100 %)
3 diff
(99.9 %id)
BF725822 eye, Iris .c 1109 to 1196 1 to 88       88/88
(100 %)
0 diff
(100 %id)
H61365 ovarian tumor, ovary .c 1116 to 1236 1 to 121       121/121
(100 %)
4 diff
(96.7 %id)
H62390 ovarian tumor, ovary .c 1557 to 1930 374 to 1       374/374
(100 %)
5 diff
(98.7 %id)
BG325121 Kidney, renal cell adenocarcinoma .d 1 to 363 1 to 367   tiling clone,   367/546
(67 %)
12 diff
(97.9 %id)
M62762   .d 162 to 1329 1 to 1160       1160/1162
(99 %)
24 diff
(98.0 %id)
TI_652739998   .d 224 to 836 16 to 631   fully sequenced, Submitted on the opposite strand 616/631
(97 %)
7 diff
(98.9 %id)
BM920722 pooled brain, lung, testis .d 228 to 995 13 to 792       780/1120
(69 %)
23 diff
(98.0 %id)
TI_44166808   .d 229 to 867 124 to 762       639/763
(83 %)
13 diff
(98.3 %id)
BM820227 stomach .d 239 to 809 1 to 571       571/571
(100 %)
0 diff
(100 %id)
BQ683536 melanotic melanoma, cell line, skin .d 240 to 521 1 to 282       282/282
(100 %)
0 diff
(100 %id)
BM849540 myeloma .d 241 to 810 1 to 570       570/570
(100 %)
0 diff
(100 %id)
BM848470 myeloma .d 241 to 706 1 to 466       466/466
(100 %)
0 diff
(100 %id)
BQ008755 Chondrosarcoma, Left Pelvis .d 244 to 1000 16 to 772     Submitted on the opposite strand 757/757
(100 %)
2 diff
(99.8 %id)
NM_001694.2   .d 244 to 1335 1 to 1092   RefSeq, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1092/1092
(100 %)
0 diff
(100 %id)
CA503074 Human Lung Epithelial cells, lung .d 244 to 948 16 to 720     Submitted on the opposite strand 705/705
(100 %)
0 diff
(100 %id)
CR592409 Placenta Cot 25-normalized .d 250 to 1306 1 to 1057       1057/1057
(100 %)
0 diff
(100 %id)
CR599309 Placenta Cot 25-normalized .d 250 to 1306 1 to 1057       1057/1057
(100 %)
0 diff
(100 %id)
CR622720 fetal liver .d 250 to 1284 1 to 1035       1035/1035
(100 %)
0 diff
(100 %id)
TI_45215062   .d 251 to 878 130 to 752       623/753
(82 %)
13 diff
(98.3 %id)
BC009290 Muscle, rhabdomyosarcoma .d 257 to 1335 1 to 1079   available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1079/1079
(100 %)
0 diff
(100 %id)
BQ949611 large cell carcinoma, lung .d 257 to 1166 1 to 913       913/913
(100 %)
8 diff
(99.2 %id)
BQ058594 lymph, lymphoma, cell line .d 258 to 1099 1 to 848       848/996
(85 %)
18 diff
(98.2 %id)
CR608280 Neuroblastoma Cot 25-normalized .d 259 to 1300 1 to 1042       1042/1042
(100 %)
0 diff
(100 %id)
CN260463 embryonic stem cells, DMSO-treated H9 cellline .d 260 to 817 1 to 558       558/558
(100 %)
0 diff
(100 %id)
BM841916 myeloma .d 260 to 810 1 to 551       551/551
(100 %)
0 diff
(100 %id)
BM782593 stomach .d 260 to 811 1 to 552       552/552
(100 %)
0 diff
(100 %id)
BM852116 stomach .d 260 to 739 1 to 480       480/480
(100 %)
0 diff
(100 %id)
CR592150 fetal brain .d 262 to 1332 1 to 1071       1071/1071
(100 %)
0 diff
(100 %id)
BM928304 brain .d 262 to 1046 1 to 787       787/1169
(67 %)
10 diff
(99.2 %id)
BM766673 Ascites, stomach .d 262 to 578 1 to 317       317/317
(100 %)
0 diff
(100 %id)
TI_57196247   .d 263 to 669 31 to 441       408/441
(92 %)
10 diff
(97.8 %id)
BM762302 myeloma .d 263 to 759 1 to 497       497/497
(100 %)
0 diff
(100 %id)
BM847525 myeloma .d 263 to 921 1 to 659       659/659
(100 %)
0 diff
(100 %id)
BM846106 myeloma .d 263 to 633 1 to 371       371/371
(100 %)
0 diff
(100 %id)
BM761564 myeloma .d 264 to 701 1 to 438       438/438
(100 %)
0 diff
(100 %id)
BM762016 myeloma .d 264 to 899 1 to 636       636/636
(100 %)
0 diff
(100 %id)
BM763817 myeloma .d 264 to 803 1 to 540       540/540
(100 %)
0 diff
(100 %id)
BM847482 myeloma .d 264 to 750 1 to 487       487/487
(100 %)
0 diff
(100 %id)
BU860168 adenocarcinoma, cell line, breast .d 266 to 1037 1 to 778       778/906
(85 %)
15 diff
(98.4 %id)
CR601237 Neuroblastoma Cot 25-normalized .d 269 to 1330 1 to 1062       1062/1062
(100 %)
0 diff
(100 %id)
BX355041 Neuroblastoma Cot 25-normalized .d 269 to 1271 1000 to 1       1000/1000
(100 %)
27 diff
(97.3 %id)
BM724170 eye, fetal eye .d 270 to 773 1 to 503   fully sequenced, Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 503/503
(100 %)
1 diff
(99.9 %id)
CA488628   .d 271 to 1224 1 to 961       961/966
(99 %)
15 diff
(98.5 %id)
TI_154189453   .d 272 to 1083 50 to 858       809/1013
(79 %)
29 diff
(97.2 %id)
CR599331 T cells (Jurkat cell line) .d 273 to 1290 1 to 1018       1018/1018
(100 %)
0 diff
(100 %id)
BC007389 Skin, melanotic melanoma. .d 274 to 1335 1 to 1062   available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1062/1062
(100 %)
0 diff
(100 %id)
BQ109401 brain .d 274 to 847 1 to 574       574/574
(100 %)
0 diff
(100 %id)
BQ224964 epithelioid carcinoma, Pancreas .d 274 to 1164 1 to 894       894/908
(98 %)
19 diff
(98.0 %id)
CF455481 peripheral nervous system .d 274 to 1080 25 to 828       804/829
(96 %)
17 diff
(98.0 %id)
BM473665 duodenal adenocarcinoma, cell line, small intestine .d 275 to 1037 1 to 765       765/1201
(63 %)
5 diff
(99.6 %id)
BU075908 insulinoma, Pancreas .d 277 to 805 1 to 529   fully sequenced, Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 529/529
(100 %)
3 diff
(99.5 %id)
BU509149 leiomyosarcoma, uterus .d 277 to 1028 1 to 761       761/923
(82 %)
22 diff
(97.7 %id)
BC004537 Skin, melanotic melanoma. .d 278 to 1335 1 to 1058   available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1058/1058
(100 %)
0 diff
(100 %id)
CR995414 T-Lymphocytes .d 278 to 1047 1 to 771       771/771
(100 %)
1 diff
(99.9 %id)
TI_154146043   .d 278 to 901 76 to 701       626/844
(74 %)
38 diff
(95.5 %id)
BU844926 ovary, teratocarcinoma, cell line .d 279 to 1055 1 to 783       783/957
(81 %)
23 diff
(97.6 %id)
TI_154147004   .d 280 to 909 81 to 708       628/628
(100 %)
41 diff
(93.5 %id)
BM924419 pooled colon, kidney, stomach .d 281 to 1037 1 to 767       767/1077
(71 %)
12 diff
(98.9 %id)
TI_154189969   .d 281 to 1063 49 to 825       777/976
(79 %)
14 diff
(98.6 %id)
BF725732 eye, Iris .d 283 to 807 1 to 525       525/525
(100 %)
0 diff
(100 %id)
BF725964 eye, Iris .d 283 to 700 1 to 418       418/418
(100 %)
0 diff
(100 %id)
CN260452 embryonic stem cells, DMSO-treated H9 cellline .d 283 to 856 1 to 574       574/574
(100 %)
0 diff
(100 %id)
BY795285 eye .d 284 to 1336 1 to 1053   tiling clone,   1053/1053
(100 %)
0 diff
(100 %id)
BQ229305 large cell carcinoma, lung .d 284 to 1236 1 to 971   AAA   971/1070
(90 %)
34 diff
(96.9 %id)
BU173627 epithelioid carcinoma, Pancreas .d 285 to 972 1 to 697       697/800
(87 %)
15 diff
(98.2 %id)
BU187117 eye, retinoblastoma .d 285 to 1058 1 to 780       780/870
(89 %)
11 diff
(98.8 %id)
BQ424541 eye, retinoblastoma .d 285 to 1129 1 to 848       848/923
(91 %)
12 diff
(98.7 %id)
BQ719173 sympathetic trunk .d 285 to 1095 1 to 811       811/883
(91 %)
23 diff
(97.4 %id)
CA488734   .d 285 to 1100 1 to 819       819/894
(91 %)
11 diff
(98.8 %id)
TI_45212204   .d 285 to 961 85 to 759       675/759
(88 %)
18 diff
(97.7 %id)
CR597229 adult brain .d 286 to 1331 1 to 1046       1046/1046
(100 %)
0 diff
(100 %id)
BM561573 blood, natural killer cells, cell line .d 286 to 1046 1 to 775       775/1097
(70 %)
18 diff
(98.4 %id)
CF127534 Chondrosarcoma Lung Metastasis cell lines, lung .d 286 to 1000 1 to 715       715/719
(99 %)
1 diff
(99.9 %id)
TI_154193059   .d 286 to 1244 51 to 999       949/1047
(90 %)
29 diff
(97.3 %id)
BM842657 lymph node, stomach .d 288 to 946 1 to 659       659/659
(100 %)
0 diff
(100 %id)
CN260449 embryonic stem cells, DMSO-treated H9 cellline .d 289 to 618 1 to 330       330/330
(100 %)
0 diff
(100 %id)
BC007759 Brain, neuroblastoma .d 290 to 1335 1 to 1046   available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1046/1046
(100 %)
1 diff
(100.0 %id)
CR996420 T-Lymphocytes .d 290 to 967 1 to 678       678/688
(98 %)
1 diff
(99.9 %id)
BM907091 brain, hippocampus .d 291 to 964 1 to 679       679/1172
(57 %)
7 diff
(99.5 %id)
BM924578 pooled colon, kidney, stomach .d 291 to 1095 1 to 810       810/1104
(73 %)
14 diff
(98.8 %id)
CB215563 normal endometrium, late proliferativephase, cycle day 13, uterus .d 291 to 946 1 to 656       656/656
(100 %)
0 diff
(100 %id)
CF126196 Chondrosarcoma Lung Metastasis cell lines, lung .d 291 to 1054 1 to 764       764/764
(100 %)
2 diff
(99.8 %id)
TI_45209433   .d 291 to 636 91 to 431       341/431
(79 %)
8 diff
(98.2 %id)
TI_154189153   .d 291 to 1141 52 to 897       846/1003
(84 %)
20 diff
(98.1 %id)
BF724419 eye, Iris .d 292 to 790 1 to 499       499/499
(100 %)
0 diff
(100 %id)
CN260451 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 292 to 946 1 to 655       655/655
(100 %)
0 diff
(100 %id)
BQ060051 lymph, lymphoma, cell line .d 292 to 1069 1 to 781       781/969
(80 %)
18 diff
(98.2 %id)
BU846257 ovary, teratocarcinoma, cell line .d 292 to 1177 1 to 896       896/951
(94 %)
21 diff
(97.8 %id)
CA487321   .d 300 to 1137 1 to 843       843/848
(99 %)
25 diff
(97.1 %id)
CA488296   .d 300 to 1001 1 to 707       707/958
(73 %)
15 diff
(98.5 %id)
CF127080 Chondrosarcoma Lung Metastasis cell lines, lung .d 300 to 996 1 to 697       697/697
(100 %)
0 diff
(100 %id)
TI_154190190   .d 300 to 1122 51 to 869   AAA   819/973
(84 %)
20 diff
(98.0 %id)
CX871003 embryonic stem .d 301 to 1015 1 to 715       715/715
(100 %)
0 diff
(100 %id)
CN260459 embryonic stem cells, DMSO-treated H9 cellline .d 303 to 764 9 to 470       462/470
(98 %)
0 diff
(100 %id)
CA455067   .d 303 to 1157 1 to 865       865/895
(96 %)
13 diff
(98.6 %id)
BF727320 eye, lens .d 306 to 987 1 to 682       682/682
(100 %)
0 diff
(100 %id)
CR600796 Placenta Cot 25-normalized .d 307 to 1255 1 to 949       949/949
(100 %)
0 diff
(100 %id)
CX756652 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 307 to 1045 1 to 730       730/877
(83 %)
13 diff
(98.6 %id)
CD515476 White Matter .d 307 to 1175 1 to 880       880/901
(97 %)
20 diff
(97.8 %id)
BQ279185 adenocarcinoma, cell line, breast .d 308 to 1095 1 to 792       792/928
(85 %)
7 diff
(99.3 %id)
BU166610 melanotic melanoma, cell line, skin .d 308 to 1158 1 to 855       855/961
(88 %)
30 diff
(96.9 %id)
BQ678034 melanotic melanoma, cell line, skin .d 308 to 1249 1 to 949       949/981
(96 %)
27 diff
(97.3 %id)
BU956550 adenocarcinoma, cell line, breast .d 308 to 1093 1 to 793       793/914
(86 %)
23 diff
(97.5 %id)
CR990404 T-Lymphocytes .d 310 to 1097 1 to 789       789/791
(99 %)
4 diff
(99.5 %id)
BF724386 eye, Iris .d 311 to 799 1 to 489       489/489
(100 %)
0 diff
(100 %id)
BQ722238 sympathetic trunk .d 311 to 1158 1 to 863       863/872
(98 %)
28 diff
(96.8 %id)
BM554691 duodenal adenocarcinoma, cell line, small intestine .d 312 to 1243 1 to 949       949/1031
(92 %)
25 diff
(97.6 %id)
BM554812 duodenal adenocarcinoma, cell line, small intestine .d 312 to 1095 1 to 792       792/1136
(69 %)
14 diff
(98.8 %id)
BU859032 ovary, teratocarcinoma, cell line .d 312 to 1109 1 to 803       803/862
(93 %)
17 diff
(98.1 %id)
TI_154194002   .d 313 to 1110 51 to 848       798/1031
(77 %)
12 diff
(98.9 %id)
BQ878221 melanotic melanoma, cell line, skin .d 314 to 1096 1 to 794       794/907
(87 %)
16 diff
(98.3 %id)
BU538818 adenocarcinoma, cell line, breast .d 319 to 1142 1 to 828       828/901
(91 %)
9 diff
(99.1 %id)
BM708486 eye, RPE and Choroid .d 320 to 778 1 to 459   fully sequenced, Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 459/459
(100 %)
0 diff
(100 %id)
BM452233 melanotic melanoma, skin .d 321 to 1095 13 to 787       775/1092
(70 %)
27 diff
(97.6 %id)
BQ053546 blood, natural killer cells, cell line .d 321 to 1231 1 to 915       915/1063
(86 %)
26 diff
(97.6 %id)
BQ232887 large cell carcinoma, lung .d 323 to 1327 1 to 1016       1016/1081
(93 %)
34 diff
(96.9 %id)
BU171824 melanotic melanoma, skin .d 323 to 1095 1 to 780       780/892
(87 %)
8 diff
(99.2 %id)
BU501943 epithelioid carcinoma cell line, Pancreas .d 324 to 1236 1 to 924       924/938
(98 %)
33 diff
(96.5 %id)
EB386136 eye, optic nerve .d 325 to 1114 1 to 790       790/790
(100 %)
0 diff
(100 %id)
BU556639 ovary, teratocarcinoma, cell line .d 327 to 1095 1 to 775       775/986
(78 %)
13 diff
(98.7 %id)
CB053526 leiomyosarcoma, soft tissue .d 335 to 947 10 to 622     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 613/622
(98 %)
6 diff
(99.1 %id)
CD612535   .d 337 to 887 556 to 7       550/556
(98 %)
1 diff
(99.9 %id)
BY997051   .d 337 to 957 16 to 636       621/636
(97 %)
6 diff
(99.1 %id)
CR590083 T cells (Jurkat cell line) Cot10-normalized .d 341 to 1332 1 to 992       992/992
(100 %)
0 diff
(100 %id)
CV337860 nervous_tumor .d 342 to 659 326 to 8     Submitted on the opposite strand 319/342
(93 %)
6 diff
(98.3 %id)
CR616464 Neuroblastoma Cot 25-normalized .d 346 to 1334 1 to 989       989/989
(100 %)
0 diff
(100 %id)
CD612534   .d 348 to 887 546 to 7       540/546
(98 %)
0 diff
(100 %id)
AW249148 lung, small cell carcinoma .d 350 to 948 9 to 607       599/607
(98 %)
6 diff
(99.1 %id)
TI_57244261   .d 351 to 1015 27 to 691       665/691
(96 %)
7 diff
(99.0 %id)
TI_227712386   .d 352 to 1335 1062 to 82   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 981/1043
(94 %)
25 diff
(97.7 %id)
BG741416 skin .d 355 to 1023 1 to 669       669/670
(99 %)
3 diff
(99.6 %id)
CN260447 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 356 to 901 1 to 546       546/546
(100 %)
0 diff
(100 %id)
AI114460 Liver .d 361 to 964 63 to 666       604/667
(90 %)
7 diff
(99.0 %id)
TI_154193551   .d 371 to 1330 50 to 987   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 938/942
(99 %)
27 diff
(97.2 %id)
CF127865 Chondrosarcoma Lung Metastasis cell lines, lung .d 372 to 1015 1 to 644       644/645
(99 %)
1 diff
(99.9 %id)
ES308508 beard hair, skin .d 377 to 543 1 to 167       167/167
(100 %)
1 diff
(99.5 %id)
BE797916 lung, small cell carcinoma .d 380 to 1027 55 to 702       648/722
(89 %)
12 diff
(98.4 %id)
TI_57149237   .d 388 to 961 28 to 601       574/601
(95 %)
6 diff
(99.1 %id)
BG697408 skin .d 389 to 1023 1 to 635       635/641
(99 %)
2 diff
(99.7 %id)
CR982994 T-Lymphocytes .d 389 to 1231 1 to 849       849/854
(99 %)
11 diff
(98.8 %id)
EL955118 eyeball .d 391 to 937 17 to 563       547/563
(97 %)
8 diff
(98.6 %id)
BM708473 eye, RPE and Choroid .d 391 to 721 1 to 331   fully sequenced, Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 331/331
(100 %)
1 diff
(99.7 %id)
BU166538 melanotic melanoma, cell line, skin .d 393 to 1162 1 to 774       774/917
(84 %)
6 diff
(99.4 %id)
BM794561 stomach .d 394 to 950 1 to 557       557/557
(100 %)
0 diff
(100 %id)
CR990925 T-Lymphocytes .d 395 to 1100 1 to 707       707/710
(99 %)
2 diff
(99.8 %id)
TI_1948098634   .d 395 to 862 121 to 588   fully sequenced,   468/495
(94 %)
7 diff
(98.6 %id)
BT007155   .d 396 to 863 1 to 468       468/468
(100 %)
0 diff
(100 %id)
CR541930   .d 396 to 863 1 to 468       468/468
(100 %)
0 diff
(100 %id)
CR541951   .d 396 to 860 1 to 465       465/465
(100 %)
0 diff
(100 %id)
BQ372825 prostate_tumor .d 412 to 706 295 to 1       295/301
(98 %)
2 diff
(99.4 %id)
BM769410 stomach .d 434 to 1064 1 to 631       631/631
(100 %)
0 diff
(100 %id)
BM769872 stomach .d 434 to 1090 1 to 657       657/657
(100 %)
0 diff
(100 %id)
BM843350 stomach .d 434 to 1067 1 to 634       634/634
(100 %)
0 diff
(100 %id)
BM818948 stomach .d 434 to 1071 1 to 638       638/638
(100 %)
0 diff
(100 %id)
BM826778 stomach .d 434 to 850 1 to 417       417/417
(100 %)
0 diff
(100 %id)
BY993860   .d 440 to 1053 10 to 623       614/623
(98 %)
6 diff
(99.1 %id)
CA946383 eye, lacrimal gland .d 450 to 615 166 to 1     Submitted on the opposite strand 166/166
(100 %)
0 diff
(100 %id)
TI_154116892   .d 465 to 1335 955 to 94   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 862/973
(88 %)
19 diff
(98.1 %id)
BE612559 adenocarcinoma, ovary .d 468 to 1016 1 to 546       546/554
(98 %)
4 diff
(99.3 %id)
TI_57147987   .d 470 to 1028 77 to 638       562/728
(77 %)
14 diff
(98.1 %id)
TI_227715768   .d 470 to 1335 944 to 80   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 865/1027
(84 %)
9 diff
(99.2 %id)
TI_227715139   .d 472 to 1333 959 to 97   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 863/1013
(85 %)
20 diff
(98.1 %id)
ES312039 frontal balding hair, skin .d 473 to 645 1 to 173       173/173
(100 %)
0 diff
(100 %id)
CD612521   .d 474 to 837 363 to 1       363/368
(98 %)
2 diff
(99.5 %id)
CD612526   .d 474 to 836 363 to 1       363/363
(100 %)
1 diff
(99.8 %id)
CD612528   .d 474 to 844 385 to 15       371/397
(93 %)
1 diff
(99.8 %id)
H43170 brain .d 474 to 841 17 to 381       365/381
(95 %)
14 diff
(96.4 %id)
TI_1948098776   .d 474 to 862 516 to 128       389/1448
(26 %)
5 diff
(99.7 %id)
CD612523   .d 476 to 837 362 to 1       362/368
(98 %)
4 diff
(99.0 %id)
CD612525   .d 476 to 837 361 to 1       361/367
(98 %)
5 diff
(98.7 %id)
BE562712 endometrium, adenocarcinoma cell line, uterus .d 476 to 1023 1 to 550       550/551
(99 %)
4 diff
(99.3 %id)
BG116379 duodenal adenocarcinoma, cell line, small intestine .d 480 to 1037 1 to 558       558/626
(89 %)
8 diff
(98.8 %id)
TI_57148482   .d 485 to 1074 78 to 665       588/666
(88 %)
15 diff
(97.8 %id)
BI759798 pooled colon, kidney, stomach .d 486 to 1074 1 to 587       587/588
(99 %)
9 diff
(98.5 %id)
H23660 brain .d 487 to 892 27 to 437       411/448
(91 %)
23 diff
(94.9 %id)
BQ362949 stomach .d 498 to 1025 1 to 528       528/536
(98 %)
10 diff
(98.2 %id)
BF981919 duodenal adenocarcinoma, cell line, small intestine .d 498 to 1025 1 to 526       526/527
(99 %)
7 diff
(98.7 %id)
BU620642 cell lines, Chondrosarcoma .d 500 to 1335 846 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 828/828
(100 %)
9 diff
(99.0 %id)
BE897736 melanotic melanoma, skin .d 513 to 1016 1 to 501       501/501
(100 %)
3 diff
(99.5 %id)
EL954162 eyeball .d 515 to 1019 1 to 506       506/506
(100 %)
3 diff
(99.5 %id)
TI_154103527   .d 519 to 1335 891 to 76   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 816/995
(82 %)
5 diff
(99.5 %id)
CD365631 Alveolar Macrophage, lung .d 524 to 1333 828 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 810/810
(100 %)
10 diff
(98.8 %id)
BQ311642 breast_normal .d 528 to 941 412 to 1       412/412
(100 %)
3 diff
(99.3 %id)
BF969634 adrenal cortex carcinoma, cell line, adrenal gland .d 528 to 1021 1 to 494   AAA   494/558
(88 %)
2 diff
(99.7 %id)
BM923528 pooled colon, kidney, stomach .d 528 to 1333 13 to 821       809/1058
(76 %)
6 diff
(99.5 %id)
AW967614   .d 533 to 1072 1 to 539       539/561
(96 %)
28 diff
(95.1 %id)
BQ010053 Chondrosarcoma, Left Pubic Bone .d 542 to 1335 811 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 793/793
(100 %)
1 diff
(99.9 %id)
BQ362607 stomach .d 543 to 767 225 to 1       225/225
(100 %)
2 diff
(99.2 %id)
CA449644 Chondrosarcoma, Left Pelvis .d 543 to 1335 808 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 790/790
(100 %)
3 diff
(99.7 %id)
CD366876 Alveolar Macrophage, lung .d 543 to 1335 810 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 792/792
(100 %)
1 diff
(99.9 %id)
TI_45379764   .d 547 to 1284 745 to 2       744/745
(99 %)
6 diff
(99.2 %id)
BQ372826 prostate_tumor .d 550 to 955 410 to 7       404/410
(98 %)
2 diff
(99.6 %id)
BQ372829 prostate_tumor .d 550 to 957 404 to 1       404/404
(100 %)
8 diff
(98.1 %id)
AA251447 germinal center B cell .d 550 to 955 19 to 422       404/422
(95 %)
19 diff
(95.5 %id)
AL120765 melanoma (MeWo cell line) .d 551 to 1003 1 to 453       453/453
(100 %)
2 diff
(99.6 %id)
TI_1948098635   .d 551 to 862 442 to 131   fully sequenced,   312/339
(92 %)
0 diff
(100 %id)
TI_652739997   .d 551 to 820 272 to 3   fully sequenced, Submitted on the opposite strand 270/272
(99 %)
0 diff
(100 %id)
CN260450 embryonic stem cells, DMSO-treated H9 cellline .d 556 to 1058 1 to 502       502/502
(100 %)
3 diff
(99.5 %id)
BQ687546 ductal carcinoma, cell line, Pancreas .d 558 to 1330 1 to 775       775/852
(90 %)
12 diff
(98.6 %id)
BQ333840 marrow .d 561 to 942 382 to 1       382/382
(100 %)
4 diff
(99.0 %id)
BQ371460 prostate_normal .d 563 to 956 404 to 11       394/404
(97 %)
0 diff
(100 %id)
BQ333842 marrow .d 564 to 956 416 to 25       392/416
(94 %)
0 diff
(100 %id)
TI_159696130   .d 564 to 1337 895 to 126   tiling clone,   770/1119
(68 %)
23 diff
(98.0 %id)
H14924 breast .d 567 to 947 1 to 383       383/390
(98 %)
13 diff
(96.7 %id)
BQ333846 marrow .d 570 to 956 404 to 18       387/404
(95 %)
0 diff
(100 %id)
CR613683 Neuroblastoma Cot 50-normalized .d 573 to 1302 1 to 730       730/730
(100 %)
0 diff
(100 %id)
BI871547 adenocarcinoma, cell line, Liver .d 575 to 1019 67 to 510       444/513
(86 %)
8 diff
(98.5 %id)
TI_57231179   .d 575 to 1019 154 to 597       444/513
(86 %)
8 diff
(98.5 %id)
BQ371457 prostate_normal .d 580 to 946 368 to 2       367/368
(99 %)
3 diff
(99.2 %id)
BE879982 large cell carcinoma, undifferentiated, lung .d 581 to 1027 1 to 447       447/788
(56 %)
7 diff
(99.2 %id)
BI764793 pooled colon, kidney, stomach .d 585 to 1025 1 to 441       441/590
(74 %)
2 diff
(99.7 %id)
TI_57147259   .d 585 to 1025 35 to 475       441/624
(70 %)
8 diff
(98.8 %id)
BE744878 adenocarcinoma cell line, ovary .d 586 to 1002 1 to 417       417/984
(42 %)
3 diff
(99.7 %id)
BG575364 breast, mammary adenocarcinoma, cell line .d 587 to 1043 1 to 458       458/761
(60 %)
7 diff
(99.1 %id)
TI_57148168   .d 588 to 1028 34 to 475       442/641
(68 %)
10 diff
(98.5 %id)
BI760397 pooled colon, kidney, stomach .d 590 to 1028 1 to 440       440/606
(72 %)
4 diff
(99.4 %id)
BI910735 leukocyte .d 591 to 1026 1 to 436       436/507
(85 %)
1 diff
(99.9 %id)
TI_57237486   .d 591 to 1026 72 to 507       436/578
(75 %)
9 diff
(98.5 %id)
BQ363476 stomach .d 594 to 1025 48 to 479       432/487
(88 %)
14 diff
(97.2 %id)
BE613128 adenocarcinoma, ovary .d 601 to 1286 689 to 2       688/690
(99 %)
0 diff
(100 %id)
CN260448 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 615 to 1064 1 to 452       452/941
(48 %)
7 diff
(99.3 %id)
BY997301   .d 618 to 1221 22 to 625       604/625
(96 %)
6 diff
(99.1 %id)
CD367100 Alveolar Macrophage, lung .d 632 to 1335 722 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 704/704
(100 %)
1 diff
(99.9 %id)
EL952329 eyeball .d 633 to 993 1 to 360       360/360
(100 %)
3 diff
(99.2 %id)
CA426172 Bone, Subchondral Bone .d 635 to 1335 717 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 699/699
(100 %)
2 diff
(99.8 %id)
CB529012 Aveolar Macrophage, lung .d 635 to 1335 719 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 701/701
(100 %)
0 diff
(100 %id)
CB529900 Aveolar Macrophage, lung .d 637 to 1335 717 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 699/699
(100 %)
0 diff
(100 %id)
R35745 placenta .d 639 to 941 1 to 307       307/312
(98 %)
15 diff
(95.2 %id)
CD368869 Alveolar Macrophage, lung .d 639 to 1335 715 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 697/697
(100 %)
0 diff
(100 %id)
BU838206 melanotic melanoma, cell line, skin .d 641 to 1335 1 to 695   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 695/695
(100 %)
0 diff
(100 %id)
BQ681490 melanotic melanoma, cell line, skin .d 641 to 1335 1 to 695   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 695/695
(100 %)
0 diff
(100 %id)
CA413348 Knee, Osteoarthritic Cartilage .d 642 to 1335 712 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 694/694
(100 %)
0 diff
(100 %id)
CN260460 embryonic stem cells, cell lines H1, H7, andH9 .d 650 to 1094 1 to 445       445/445
(100 %)
0 diff
(100 %id)
CN481759 eye .d 653 to 1244 1 to 592       592/592
(100 %)
0 diff
(100 %id)
BU194635 melanotic melanoma, cell line, skin .d 656 to 1316 4 to 665       662/938
(70 %)
16 diff
(98.3 %id)
TI_57220542   .d 656 to 1080 45 to 463       419/494
(84 %)
17 diff
(96.6 %id)
BF727267 eye, lens .d 659 to 1314 1 to 656       656/656
(100 %)
0 diff
(100 %id)
BQ315332 epid_tumor .d 666 to 995 330 to 1       330/330
(100 %)
4 diff
(98.8 %id)
CK725181 Chondrosarcoma, Left Pubic Bone .d 667 to 1335 687 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 669/669
(100 %)
0 diff
(100 %id)
BM887954 eye .d 671 to 1018 1 to 348       348/350
(99 %)
2 diff
(99.5 %id)
BQ021350 lung, Metastatic Chondrosarcoma .d 679 to 1335 675 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 657/659
(99 %)
2 diff
(99.7 %id)
TI_59395326   .d 679 to 1260 589 to 1       589/593
(99 %)
30 diff
(95.0 %id)
TI_149315171   .d 679 to 1335 729 to 83   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 647/929
(69 %)
20 diff
(97.9 %id)
BQ898085 epidermoid carcinoma, cell line, salivary gland .d 683 to 1335 1 to 653   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 653/654
(99 %)
1 diff
(99.9 %id)
BU617833 cell lines, Chondrosarcoma .d 686 to 1335 668 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 650/650
(100 %)
0 diff
(100 %id)
CA419705 Bone, Human Chondrosarcoma Cell Line .d 689 to 1335 665 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 647/651
(99 %)
4 diff
(99.4 %id)
BU730782 eye, RPE and Choroid .d 691 to 1335 663 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 645/645
(100 %)
0 diff
(100 %id)
CD612530   .d 697 to 1007 330 to 19       312/330
(94 %)
0 diff
(100 %id)
CD612531   .d 697 to 1007 1 to 311       311/330
(94 %)
2 diff
(99.4 %id)
CA425429 cell lines, Chondrosarcoma .d 698 to 1335 656 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 638/638
(100 %)
0 diff
(100 %id)
BU628517 Bone, Enchondroma cell line .d 698 to 1335 656 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 638/638
(100 %)
0 diff
(100 %id)
BU626209 cell lines, Enchondroma .d 698 to 1335 656 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 638/646
(98 %)
0 diff
(100 %id)
BU931095 ovary, teratocarcinoma, cell line .d 708 to 1334 1 to 627   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 627/627
(100 %)
0 diff
(100 %id)
CR603009 HeLa cells Cot 25-normalized .d 710 to 1336 1 to 627       627/627
(100 %)
0 diff
(100 %id)
BQ019441 Chondrosarcoma, Left Pubic Bone .d 722 to 1335 631 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 613/613
(100 %)
1 diff
(99.9 %id)
BI768119 pooled lung and spleen .d 723 to 1025 1 to 303       303/306
(99 %)
2 diff
(99.4 %id)
BI833475 pooled pancreas and spleen .d 723 to 1034 1 to 314       314/346
(90 %)
7 diff
(98.0 %id)
TI_57180570   .d 723 to 1025 28 to 330       303/333
(90 %)
2 diff
(99.4 %id)
TI_57166554   .d 723 to 1034 37 to 350       314/382
(82 %)
7 diff
(98.2 %id)
CA426459 cell lines, Chondrosarcoma .d 723 to 1335 631 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 613/613
(100 %)
0 diff
(100 %id)
BQ333838 marrow .d 726 to 953 228 to 1       228/228
(100 %)
5 diff
(97.9 %id)
BI837362 pooled pancreas and spleen .d 734 to 993 1 to 259       259/510
(50 %)
2 diff
(99.7 %id)
EL948445 eyeball .d 738 to 1026 19 to 307       289/307
(94 %)
6 diff
(98.1 %id)
BM680335 eye, fetal eye .d 743 to 1335 611 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 593/593
(100 %)
0 diff
(100 %id)
BP432255   .d 747 to 1071 1 to 325       325/325
(100 %)
5 diff
(98.5 %id)
CA428886 Bone, Subchondral Bone .d 747 to 1335 607 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 589/607
(97 %)
1 diff
(99.9 %id)
BU730793 eye, RPE and Choroid .d 748 to 1335 606 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 588/588
(100 %)
2 diff
(99.7 %id)
BF819278 colon_ins .d 749 to 916 189 to 21     Submitted on the opposite strand 169/189
(89 %)
0 diff
(100 %id)
AA364995 pineal body .d 754 to 945 1 to 192       192/196
(97 %)
4 diff
(98.0 %id)
AA305482 colon .d 757 to 1010 8 to 261       254/261
(97 %)
6 diff
(97.8 %id)
AW955494   .d 758 to 1029 1 to 272       272/417
(65 %)
5 diff
(98.9 %id)
CU447362 epidermis .d 759 to 1056 10 to 307       298/324
(91 %)
6 diff
(98.2 %id)
TI_159689225   .d 759 to 1335 671 to 91   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 581/1021
(56 %)
25 diff
(97.6 %id)
AW844949 colon .d 762 to 1031 24 to 293       270/293
(92 %)
6 diff
(98.0 %id)
H21553 brain .d 767 to 955 58 to 245       188/246
(76 %)
3 diff
(98.8 %id)
H40069 brain .d 768 to 956 45 to 236       192/236
(81 %)
6 diff
(97.5 %id)
BG898642 cartilage .d 772 to 1336 650 to 86       565/650
(86 %)
0 diff
(100 %id)
AA377677 synovial membrane .d 774 to 1069 1 to 295       295/295
(100 %)
1 diff
(99.7 %id)
BU075729 insulinoma, Pancreas .d 775 to 1335 582 to 22   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 561/561
(100 %)
0 diff
(100 %id)
BF893067 marrow .d 777 to 995 1 to 217       217/217
(100 %)
6 diff
(97.3 %id)
BG480419 choriocarcinoma, placenta .d 785 to 1021 1 to 231       231/262
(88 %)
9 diff
(96.6 %id)
EC582118 Prostate .d 786 to 865 1 to 80       80/90
(88 %)
4 diff
(95.6 %id)
H39675 breast .d 792 to 1029 1 to 236       236/239
(98 %)
3 diff
(98.8 %id)
AW581287 leiomios .d 800 to 1016 229 to 2       228/229
(99 %)
0 diff
(100 %id)
BM855527 stomach .d 803 to 1067 1 to 265       265/265
(100 %)
1 diff
(99.7 %id)
BM688338 eye, human retina .d 804 to 1262 9 to 467       459/467
(98 %)
1 diff
(99.8 %id)
BE731494 choriocarcinoma, placenta .d 807 to 1021 1 to 217       217/217
(100 %)
4 diff
(98.2 %id)
BP330159 rectum .d 834 to 1335 1 to 502   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 502/502
(100 %)
0 diff
(100 %id)
BM741548 stomach .d 834 to 1016 1 to 183       183/183
(100 %)
0 diff
(100 %id)
TI_153949384   .d 859 to 1335 81 to 557   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 477/477
(100 %)
3 diff
(99.4 %id)
AI887500 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 869 to 1335 467 to 1       467/467
(100 %)
0 diff
(100 %id)
BM662880 eye, Retina Foveal and Macular .d 869 to 1335 484 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 467/467
(100 %)
0 diff
(100 %id)
CB143505 Liver .d 873 to 1336 479 to 16     Submitted on the opposite strand 464/479
(96 %)
0 diff
(100 %id)
F30715 pectoral muscle (after mastectomy) .d 874 to 1176 1 to 303       303/303
(100 %)
0 diff
(100 %id)
AA369054 placenta .d 876 to 1066 1 to 191       191/191
(100 %)
0 diff
(100 %id)
AI125759   .d 881 to 1335 470 to 16   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 455/455
(100 %)
0 diff
(100 %id)
BM784555 lymph node, stomach .d 881 to 1255 1 to 375       375/375
(100 %)
0 diff
(100 %id)
BQ130798 insulinoma, Pancreas .d 884 to 1335 1 to 452   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 452/452
(100 %)
5 diff
(98.9 %id)
AI092943 heart .d 888 to 1335 448 to 1       448/448
(100 %)
0 diff
(100 %id)
AI127466 heart .d 894 to 1336 443 to 1       443/443
(100 %)
0 diff
(100 %id)
AI921335 adenocarcinoma, Pancreas .d 916 to 1335 420 to 1       420/420
(100 %)
0 diff
(100 %id)
AI754806 bone marrow stroma .d 917 to 1335 438 to 20   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 419/419
(100 %)
0 diff
(100 %id)
BQ361128 ovary .d 920 to 1054 144 to 12       133/145
(91 %)
0 diff
(100 %id)
TI_151699048   .d 926 to 1335 531 to 122       410/639
(64 %)
0 diff
(100 %id)
BQ478522 insulinoma, Pancreas .d 927 to 1335 1 to 409   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 409/409
(100 %)
4 diff
(99.1 %id)
AA372116 parathyroid gland .d 928 to 1182 1 to 255       255/255
(100 %)
0 diff
(100 %id)
EL951031 eyeball .d 928 to 1078 1 to 151       151/153
(98 %)
3 diff
(98.1 %id)
AI553801 anaplastic oligodendroglioma, brain .d 949 to 1335 387 to 1       387/387
(100 %)
0 diff
(100 %id)
AI865257 lymph node, lymphoma, follicular mixed small and largecell .d 952 to 1335 384 to 1       384/384
(100 %)
0 diff
(100 %id)
BE139050 lung, two pooled squamous cell carcinomas .d 952 to 1335 384 to 1       384/384
(100 %)
0 diff
(100 %id)
AI583012 adenocarcinoma, Pancreas .d 956 to 1323 371 to 5       367/371
(98 %)
0 diff
(100 %id)
AI342392 uterus .d 957 to 1335 379 to 1       379/379
(100 %)
0 diff
(100 %id)
AW246536 lung, small cell carcinoma .d 957 to 1335 389 to 11   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 379/379
(100 %)
0 diff
(100 %id)
AW248720 lung, small cell carcinoma .d 960 to 1330 392 to 17   AAA   376/381
(98 %)
0 diff
(100 %id)
BF475400 sciatic nerve .d 973 to 1336 364 to 1       364/364
(100 %)
0 diff
(100 %id)
N21449 melanocyte .d 1014 to 1104 91 to 1       91/91
(100 %)
1 diff
(99.0 %id)
AI270767 ovary, tumor, 5 pooled (see description) .d 1038 to 1335 298 to 1       298/298
(100 %)
0 diff
(100 %id)
BM918563 pooled pancreas and spleen .d 1052 to 1335 1 to 284   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 284/284
(100 %)
0 diff
(100 %id)
DR978248 brain .d 1072 to 1334 1 to 262     Submitted on the opposite strand 262/272
(96 %)
4 diff
(98.6 %id)
W94489 heart .d 1077 to 1335 269 to 1       269/281
(95 %)
5 diff
(98.3 %id)
M86032   .d 1093 to 1335 251 to 8       244/251
(97 %)
0 diff
(100 %id)
AW951239   .d 1095 to 1335 1 to 241   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 241/241
(100 %)
0 diff
(100 %id)
BU618349 Cell Line, Chondrosarcoma .d 1095 to 1335 259 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 241/241
(100 %)
0 diff
(100 %id)
AI420559 Prostate .d 1106 to 1336 231 to 1       231/231
(100 %)
0 diff
(100 %id)
R35641 placenta .d 1109 to 1315 207 to 1       207/207
(100 %)
5 diff
(97.6 %id)
H23615 brain .d 1109 to 1259 151 to 1       151/151
(100 %)
0 diff
(100 %id)
H40278 brain .d 1109 to 1257 149 to 1       149/149
(100 %)
0 diff
(100 %id)
H43106 brain .d 1109 to 1258 150 to 1       150/150
(100 %)
1 diff
(99.4 %id)
H28674 breast .d 1115 to 1251 138 to 2       137/138
(99 %)
0 diff
(100 %id)
CB331944   .d 1122 to 1329 210 to 1     Submitted on the opposite strand 210/210
(100 %)
6 diff
(97.2 %id)
BF514630   .d 1126 to 1295 1 to 170   AAA Submitted on the opposite strand 170/173
(98 %)
10 diff
(94.3 %id)
BF516013   .d 1128 to 1287 3 to 162   AAA Submitted on the opposite strand 160/162
(98 %)
6 diff
(96.3 %id)
AW246577 lung, small cell carcinoma .d 1144 to 1335 202 to 11   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 192/192
(100 %)
0 diff
(100 %id)
BI335766 skin .d 1154 to 1336 212 to 30       183/212
(86 %)
0 diff
(100 %id)
BE645657 Prostate .d 1154 to 1335 182 to 1       182/182
(100 %)
0 diff
(100 %id)
CB053525 leiomyosarcoma, soft tissue .d 1212 to 1335 147 to 24   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 124/124
(100 %)
0 diff
(100 %id)
AA716053 pineal gland .d 1219 to 1335 117 to 1       117/117
(100 %)
6 diff
(94.9 %id)
BM750354 stomach .d 1219 to 1334 1 to 116   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 116/116
(100 %)
0 diff
(100 %id)
EC477456 Prostate .d 1229 to 1316 87 to 1       87/97
(89 %)
4 diff
(95.9 %id)
EC486783 Prostate .d 1231 to 1334 105 to 3       103/105
(98 %)
0 diff
(100 %id)
EC514457 Prostate .d 1231 to 1334 106 to 3       104/106
(98 %)
0 diff
(100 %id)
EC440947 Prostate .d 1234 to 1334 103 to 3       101/103
(98 %)
0 diff
(100 %id)
EC445166 Prostate .d 1234 to 1335 112 to 8       105/114
(92 %)
0 diff
(100 %id)
EC448920 Prostate .d 1234 to 1334 114 to 14       101/116
(87 %)
0 diff
(100 %id)
EC451353 Prostate .d 1234 to 1334 115 to 15       101/117
(86 %)
0 diff
(100 %id)
EC468736 Prostate .d 1234 to 1334 103 to 3       101/105
(96 %)
0 diff
(100 %id)
EC483700 Prostate .d 1234 to 1334 103 to 3       101/105
(96 %)
0 diff
(100 %id)
EC490981 Prostate .d 1234 to 1334 103 to 5       99/105
(94 %)
0 diff
(100 %id)
EC509230 Prostate .d 1234 to 1334 113 to 15       99/115
(86 %)
0 diff
(100 %id)
EC519953 Prostate .d 1234 to 1336 109 to 7       103/111
(92 %)
0 diff
(100 %id)
EC570810 Prostate .d 1234 to 1334 103 to 3       101/105
(96 %)
0 diff
(100 %id)
EC580362 Prostate .d 1234 to 1336 107 to 7       101/109
(92 %)
0 diff
(100 %id)
AW611563 Kidney .d 1264 to 1336 73 to 1       73/73
(100 %)
0 diff
(100 %id)
BX648283 human endometrium carcinoma cell line .e 1 to 5317 1 to 5316 D34N tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 5316/5316
(100 %)
7 diff
(99.9 %id)
DA571035 whole embryo, mainly head .e 1597 to 2380 2 to 789   capped   788/790
(99 %)
7 diff
(99.2 %id)
Z44858 brain, total brain .e 1623 to 1945 1 to 321       321/321
(100 %)
3 diff
(99.1 %id)
H09496 whole brain .e 1637 to 2048 1 to 420       420/420
(100 %)
22 diff
(94.8 %id)
BM716480 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 2143 to 2669 1 to 522   fully sequenced,   522/522
(100 %)
1 diff
(99.9 %id)
CK825939 Pancreas, Purified pancreatic islet .e 2475 to 3085 611 to 1     Submitted on the opposite strand 611/611
(100 %)
1 diff
(99.9 %id)
BQ287829 Pancreas, Purified pancreatic islet .e 2496 to 3075 580 to 1       580/580
(100 %)
1 diff
(99.9 %id)
N74056 liver and spleen .e 2516 to 3076 575 to 1       575/575
(100 %)
18 diff
(96.9 %id)
BE467119 carcinoid, lung .e 2518 to 3023 506 to 1       506/506
(100 %)
0 diff
(100 %id)
AW237035 pooled germ cell tumors .e 2524 to 2973 458 to 9       450/458
(98 %)
0 diff
(100 %id)
AI141678 pooled germ cell tumors .e 2538 to 3087 550 to 1       550/550
(100 %)
0 diff
(100 %id)
AA934774 Kidney .e 2539 to 3076 535 to 1       535/535
(100 %)
8 diff
(98.6 %id)
AW978722   .e 2550 to 3075 526 to 1     Submitted on the opposite strand 526/527
(99 %)
1 diff
(99.9 %id)
TI_157596188   .e 2570 to 3076 604 to 98   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 507/747
(67 %)
4 diff
(99.5 %id)
BU754568 placenta .e 2570 to 3076 524 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 506/510
(99 %)
3 diff
(99.5 %id)
DB357851 whole embryo, mainly head .e 2581 to 3076 495 to 1       495/542
(91 %)
4 diff
(99.3 %id)
BU753817 placenta .e 2594 to 3076 500 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 483/483
(100 %)
0 diff
(100 %id)
BU753816 placenta .e 2603 to 3076 491 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 474/474
(100 %)
10 diff
(97.9 %id)
CR624902 T cells (Jurkat cell line) .e 2606 to 3189 1 to 584       584/584
(100 %)
0 diff
(100 %id)
AI761408 pooled .e 2615 to 3075 461 to 1       461/461
(100 %)
0 diff
(100 %id)
BU738540 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 2639 to 3089 455 to 1   fully sequenced,   455/455
(100 %)
2 diff
(99.6 %id)
AI934521 anaplastic oligodendroglioma, brain .e 2678 to 3077 400 to 1       400/400
(100 %)
5 diff
(98.8 %id)
H09497 whole brain .e 2717 to 3084 378 to 1       378/460
(82 %)
10 diff
(97.9 %id)
AI817896 anaplastic oligodendroglioma, brain .e 2720 to 3076 357 to 1       439/489
(89 %)
12 diff
(97.6 %id)
BF436248 pooled .e 2720 to 3075 356 to 1       356/356
(100 %)
0 diff
(100 %id)
AI479668 anaplastic oligodendroglioma, brain .e 2723 to 3076 354 to 1       354/354
(100 %)
0 diff
(100 %id)
H62600 liver and spleen .e 2725 to 3075 355 to 2     Submitted on the opposite strand 354/360
(98 %)
0 diff
(100 %id)
Z40632 brain, total brain .e 2769 to 3076 308 to 1       308/308
(100 %)
0 diff
(100 %id)
BF727385 eye, lens .e 2770 to 3230 1 to 461       461/461
(100 %)
2 diff
(99.6 %id)
AA832081 germinal center B cell .e 2815 to 3086 271 to 1       271/280
(96 %)
1 diff
(99.7 %id)
DA522706 brain .e 2853 to 3134 2 to 284   capped   283/283
(100 %)
1 diff
(99.7 %id)
CA420215 Bone, Human Chondrosarcoma Cell Line .e 2858 to 3586 1 to 730   AAA Submitted on the opposite strand 730/730
(100 %)
11 diff
(98.5 %id)
DA748759   .e 2912 to 3487 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA789349 brain .e 2914 to 3441 2 to 530   capped   529/529
(100 %)
2 diff
(99.7 %id)
DA030293   .e 3108 to 3679 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
TI_159689576   .e 3150 to 3698 123 to 669     Submitted on the opposite strand 547/1111
(49 %)
13 diff
(98.9 %id)
DA659307   .e 3214 to 3778 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
CD172495 White Matter .e 3335 to 4131 1 to 800       800/904
(88 %)
19 diff
(97.9 %id)
CR746182 Kidney .e 3451 to 3842 1 to 392       392/392
(100 %)
2 diff
(99.5 %id)
BF811440 colon_ins .e 3461 to 3710 1 to 251       251/293
(85 %)
8 diff
(97.3 %id)
AI950281 pooled germ cell tumors .e 3476 to 3771 23 to 308     Submitted on the opposite strand 286/331
(86 %)
14 diff
(95.8 %id)
AI769505 Kidney .e 3490 to 3940 451 to 1       451/451
(100 %)
2 diff
(99.6 %id)
BF762500 colon_est .e 3577 to 3924 1 to 345       345/345
(100 %)
8 diff
(97.7 %id)
DA749476   .e 3667 to 4217 2 to 552   tiling clone, capped   551/551
(100 %)
2 diff
(99.7 %id)
BQ648729 hepatocellular carcinoma, cell line, Liver .e 3995 to 4819 21 to 856   AAA   836/930
(89 %)
6 diff
(99.4 %id)
BF687752 brain, glioblastoma .e 4085 to 4631 15 to 568       554/693
(79 %)
6 diff
(99.2 %id)
BX104573 liver and spleen .e 4289 to 4970 1 to 682       682/682
(100 %)
0 diff
(100 %id)
BF037479 adenocarcinoma, ovary .e 4298 to 4972 1 to 675       675/675
(100 %)
5 diff
(99.3 %id)
AI375672 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 4335 to 4747 1 to 413     Submitted on the opposite strand 413/413
(100 %)
0 diff
(100 %id)
BQ668572 epidermoid carcinoma, cell line, salivary gland .e 4375 to 5082 1 to 716       716/945
(75 %)
23 diff
(97.6 %id)
N59073 liver and spleen .e 4400 to 4736 1 to 341       341/345
(98 %)
11 diff
(96.9 %id)
EL954594 eyeball .e 4428 to 4997 1 to 570       570/570
(100 %)
4 diff
(99.3 %id)
BI192993 epithelioid carcinoma cell line, Pancreas .e 4553 to 5090 1 to 547       547/549
(99 %)
17 diff
(97.0 %id)
AA358357 lung .e 4587 to 4926 1 to 342       342/343
(99 %)
5 diff
(98.6 %id)
AA089702   .e 4604 to 4927 20 to 336       317/336
(94 %)
6 diff
(98.3 %id)
DB574187 hypothalamus .e 4607 to 5322 1 to 715   tiling clone, Submitted on the opposite strand 715/715
(100 %)
6 diff
(99.2 %id)
BG827382 muscle, rhabdomyosarcoma .e 4687 to 5325 1 to 642       642/652
(98 %)
9 diff
(98.7 %id)
BE907654 epithelioid carcinoma, Pancreas .e 4694 to 5277 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
BF698276 brain, primitive neuroectoderm .e 4703 to 5318 1 to 611   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 611/614
(99 %)
14 diff
(97.8 %id)
AV719262 corresponding non cancerous liver tissue .e 4733 to 5321 589 to 1     Submitted on the opposite strand 589/589
(100 %)
4 diff
(99.4 %id)
BG236006 blood, lymphocyte .e 4754 to 5320 567 to 1       567/567
(100 %)
0 diff
(100 %id)
AI885798 anaplastic oligodendroglioma, brain .e 4773 to 5317 556 to 12   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 545/545
(100 %)
2 diff
(99.7 %id)
AI363295 brain, glioblastoma (pooled) .e 4802 to 5317 516 to 1       516/516
(100 %)
0 diff
(100 %id)
AW134784   .e 4890 to 5317 445 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 428/428
(100 %)
3 diff
(99.3 %id)
BM692623 eye, human retina .e 4929 to 5317 1 to 389   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 389/389
(100 %)
0 diff
(100 %id)
BE695020 breast .e 4954 to 5311 358 to 1       358/358
(100 %)
1 diff
(99.8 %id)
AI199473 anaplastic oligodendroglioma, brain .e 4961 to 5317 357 to 1       357/357
(100 %)
1 diff
(99.8 %id)
T34413 lung .e 4976 to 5322 347 to 1       347/347
(100 %)
2 diff
(99.5 %id)
DR760173 embryonic stem .e 5012 to 5324 336 to 23     Submitted on the opposite strand 314/336
(93 %)
0 diff
(100 %id)
T23875   .e 5022 to 5320 299 to 1       299/299
(100 %)
5 diff
(98.4 %id)
AI744064 Prostate .e 5028 to 5317 330 to 41   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 290/290
(100 %)
0 diff
(100 %id)
AI685478 Prostate .e 5081 to 5322 256 to 15   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 242/242
(100 %)
0 diff
(100 %id)
BE077166 breast .e 5116 to 5313 1 to 198       198/209
(94 %)
5 diff
(97.7 %id)
BE077171 breast .e 5116 to 5313 1 to 198       198/209
(94 %)
5 diff
(97.7 %id)
T23932   .e 5130 to 5321 192 to 1       192/199
(96 %)
3 diff
(98.5 %id)
DB252714 uterus .f 1 to 570 2 to 571 exact tiling clone, capped   570/570
(100 %)
0 diff
(100 %id)
BM466399 eye, retinoblastoma .g-u 1 to 815 1 to 821   tiling clone,   821/1054
(77 %)
17 diff
(98.4 %id)
BX648053 fetal brain .g-u 400 to 2906 1 to 2507 exact tiling clone, available from DKFZ, AAA   2507/2507
(100 %)
4 diff
(99.9 %id)
BG471571 eye, retinoblastoma .g-u 822 to 1459 1 to 651       651/771
(84 %)
24 diff
(96.9 %id)
BM726801 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .g-u 954 to 1532 1 to 579   tiling clone,   579/579
(100 %)
0 diff
(100 %id)
BM452458 eye, retinoblastoma .g-u 1342 to 2135 1 to 798 exact     798/1085
(73 %)
15 diff
(98.7 %id)
BF922352 nervous_tumor .g-u 2019 to 2452 18 to 451       434/451
(96 %)
6 diff
(98.7 %id)
BF922421 nervous_tumor .g-u 2019 to 2238 220 to 2     Submitted on the opposite strand 219/238
(92 %)
0 diff
(100 %id)
TI_151727879   .g-u 2216 to 2903 760 to 71   AAA   690/690
(100 %)
13 diff
(98.2 %id)
BM986837 mixed .g-u 2513 to 2903 409 to 19   tiling clone, AAA   391/399
(97 %)
1 diff
(99.8 %id)
AA455060 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g-u 2561 to 2917 356 to 2   tiling clone,   355/356
(99 %)
0 diff
(100 %id)
AW297423   .h 1 to 432 1 to 432   tiling clone, Submitted on the opposite strand 432/432
(100 %)
2 diff
(99.6 %id)
CR999328 T-Lymphocytes .h 78 to 391 1 to 315   tiling clone,   315/316
(99 %)
3 diff
(99.1 %id)
BI916587 brain .h 356 to 1028 1 to 672 exact tiling clone,   672/674
(99 %)
13 diff
(98.1 %id)
TI_57240056   .h 356 to 1028 32 to 703 exact     672/705
(95 %)
18 diff
(97.5 %id)
AW957968   .i 1 to 643 21 to 663 G77C A79X A95P S110F T111P ... tiling clone,   643/663
(96 %)
21 diff
(96.9 %id)
AA316707 colon .i 6 to 438 26 to 457       432/457
(94 %)
7 diff
(98.5 %id)
CR616665 fetal brain .i 188 to 1056 1 to 869 exact tiling clone,   869/869
(100 %)
0 diff
(100 %id)
AA248867   Gene TBC1D24andATP6V0C, variant not shown         This clone was ignored    
AA295295 Pancreas Gene TBC1D24andATP6V0C, variant not shown         This clone was ignored    
AL556995 T cells (Jurkat cell line), T cells from T cell leukemia Gene TBC1D24andATP6V0C, variant not shown       fully sequenced, This clone was ignored    
AL579106 T cells (Jurkat cell line), T cells from T cell leukemia Gene TBC1D24andATP6V0C, variant not shown       fully sequenced, This clone was ignored    
FN112700 breast carcinoma Gene TBC1D24andATP6V0C, variant not shown         This clone was ignored    
AV686578 hepatocellular carcinoma Gene TBC1D24andATP6V0C, variant not shown         Suspected internal deletion, this clone was ignored    
AV700638 hepatocellular carcinoma Gene TBC1D24andATP6V0C, variant not shown         Suspected internal deletion, this clone was ignored    
AV660481 corresponding non cancerous liver tissue Gene TBC1D24andATP6V0C, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BQ639726 eye, retina Gene TBC1D24andATP6V0C, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BJ996656 hepatoblastoma Gene TBC1D24andATP6V0C, variant not shown         Suspected internal deletion, this clone was ignored    
BJ996657 hepatoblastoma Gene TBC1D24andATP6V0C, variant not shown         Suspected internal deletion, this clone was ignored    
AA993430   Gene TBC1D24andATP6V0C, variant not shown         Suspected internal deletion, this clone was ignored    
AI371326 2 pooled tumors (clear cell type), Kidney Gene TBC1D24andATP6V0C, variant not shown         Suspected internal deletion, this clone was ignored    
AI827919 pooled Gene TBC1D24andATP6V0C, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BF513015   Gene TBC1D24andATP6V0C, variant not shown       AAA Submitted on the opposite strand    
BE729170 melanotic melanoma, skin Gene TBC1D24andATP6V0C, variant not shown         Suspected internal deletion, this clone was ignored    
BG743297 skin Gene TBC1D24andATP6V0C, variant not shown         This clone was ignored    
BI764224 pooled colon, kidney, stomach Gene TBC1D24andATP6V0C, variant not shown         Suspected internal deletion, this clone was ignored    
BU164700 epithelioid carcinoma, Pancreas Gene TBC1D24andATP6V0C, variant not shown         This clone was ignored    
TI_57148661   Gene TBC1D24andATP6V0C, variant not shown         Suspected internal deletion, this clone was ignored    
CA427757 Bone, Subchondral Bone Gene TBC1D24andATP6V0C, variant not shown       AAA Suspected internal deletion, this clone was ignored    
CA427769 Bone, Subchondral Bone Gene TBC1D24andATP6V0C, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h, .i Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI